MeSH Browser

MeSH Heading: Immunoproliferative Small Intestinal Disease
Tree Number(s): C04.557.386.390; C06.301.371.411.512; C06.405.249.411.512; C06.405.469.491.505; C15.378.147.780.490.512; C15.604.515.435.512; C20.683.515.512; C20.683.780.490.512
Unique ID: D007161
RDF Unique Identifier: http://id.nlm.nih.gov/mesh/D007161
Scope Note: A condition that is caused by HYPERPLASIA of LYMPHOCYTES in the small intestine (INTESTINE, SMALL) and the mesenteric LYMPH NODES. These lymphocytes produce an anomalous alpha heavy chain protein. Generally, these IPSID patients have either concurrent LYMPHOMA or develop lymphoma within a few years. The disease was first described in the Mediterranean region and is characterized by malabsorption; WEIGHT LOSS; DIARRHEA; and STEATORRHEA.
Entry Version: IMMUNOPROLIFERATIVE SMALL INTESTINAL DIS
Entry Term(s): Heavy Chain Disease, IgA Type; IPSID; Lymphoma, Mediterranean; alpha-Chain Disease
Previous Indexing: Heavy Chain Disease (1966-1986); Intestinal Neoplasms (1966-1986); Lymphoma (1966-1986)
Public MeSH Note: 87
History Note: 87
Date Established: 1987/01/01
Date of Entry: 1986/06/24
Revision Date: 2018/06/29

Allowable Qualifiers: blood (BL)

cerebrospinal fluid (CF)

chemically induced (CI)

classification (CL)

complications (CO)

congenital (CN)

diagnosis (DI)

diagnostic imaging (DG)

diet therapy (DH)

drug therapy (DT)

economics (EC)

embryology (EM)

enzymology (EN)

epidemiology (EP)

ethnology (EH)

etiology (ET)

genetics (GE)

history (HI)

immunology (IM)

metabolism (ME)

microbiology (MI)

mortality (MO)

nursing (NU)

parasitology (PS)

pathology (PA)

physiopathology (PP)

prevention & control (PC)

psychology (PX)

radiotherapy (RT)

rehabilitation (RH)

surgery (SU)

therapy (TH)

urine (UR)

veterinary (VE)

virology (VI)

Concept UI: M0011165
Scope Note: A condition that is caused by HYPERPLASIA of LYMPHOCYTES in the small intestine (INTESTINE, SMALL) and the mesenteric LYMPH NODES. These lymphocytes produce an anomalous alpha heavy chain protein. Generally, these IPSID patients have either concurrent LYMPHOMA or develop lymphoma within a few years. The disease was first described in the Mediterranean region and is characterized by malabsorption; WEIGHT LOSS; DIARRHEA; and STEATORRHEA.
Terms: Immunoproliferative Small Intestinal Disease Preferred Term
Term UI T021485
Date01/01/1999
LexicalTag NON
ThesaurusID NLM (1987); IPSID
Term UI T021486
Date06/24/1986
LexicalTag ABB
ThesaurusID UNK (19XX); Heavy Chain Disease, IgA Type
Term UI T021484
Date06/24/1986
LexicalTag NON
ThesaurusID UNK (19XX); Lymphoma, Mediterranean
Term UI T021487
Date06/24/1986
LexicalTag EPO
ThesaurusID UNK (19XX); alpha-Chain Disease
Term UI T021483
Date06/24/1986
LexicalTag NON
ThesaurusID UNK (19XX)

Immunoproliferative Small Intestinal Disease MeSH Descriptor Data 2023